Biolattice Ophthalmics, Inc.
Philadelphia, US · 1 known investors
BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.
BiotechHealthtechMedical Devices